Abstract:Aging biomarkers can potentially allow researchers to rapidly monitor the impact of an aging intervention, without the need for decade-spanning trials, by acting as surrogate endpoints. Prior to testing whether aging biomarkers may be useful as surrogate endpoints, it is first necessary to determine whether they are responsive to interventions that target aging. Epigenetic clocks are aging biomarkers based on DNA methylation with prognostic value for many aging outcomes. Many individual studies are beginning to explore whether epigenetic clocks are responsive to interventions. However, the diversity of both interventions and epigenetic clocks in different studies make them difficult to compare systematically. Here, we curate TranslAGE-Response, a harmonized database of 51 public and private longitudinal interventional studies and calculate a consistent set of 16 prominent epigenetic clocks for each study, along with 95 other DNAm biomarkers that help explain changes in each clock. With this database, we discover patterns of responsiveness across a variety of interventions and DNAm biomarkers. For example, clocks trained to predict mortality or pace of aging have the strongest response across all interventions and show consistent agreement with each other, pharmacological and lifestyle interventions drive the strongest response from DNAm biomarkers, and study population and study duration are key factors in driving responsiveness of DNAm biomarkers in an intervention. Some classes of interventions such as TNF-alpha inhibitors have strong, consistent effects across multiple studies, while others such as senolytic drugs have inconsistent effects. Clocks with multiple sub-scores (i.e. "explainable clocks") provide specificity and greater mechanistic insight into responsiveness of interventions than single-score clocks. Our work can help the geroscience field design future clinical trials, by guiding the choice of interventions, specific subsets of epigenetic clocks to minimize multiple testing, study duration, study population, and sample size, with the eventual aim of determining whether epigenetic clocks can be used as surrogate endpoints.

Next Generation Aging Clock: A Novel Approach to Decoding Human Aging Through Over 3000 Cellular Pathways

An evaluation of aging measures: from biomarkers to clocks

Models for Evaluation of Biological Age Based on Multi-omics

Comparative analysis of epigenetic aging clocks from CpG characteristics to functional associations

High-dimensional Ageome Representations of Biological Aging across Functional Modules

Decoding aging clocks: New insights from metabolomics

Comprehensive Insights from Molecular Targets and Biomarkers to Biological Clocks

Assessing the rate of aging to monitor aging itself.

Epigenetic clock: A promising biomarker and practical tool in aging

The Ticking of Aging Clocks.

Application of AI in biological age prediction

An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging

Deciphering clock genes as emerging targets against aging

DNA Methylation Clocks and Their Predictive Capacity for Aging Phenotypes and Healthspan

Tissue clocks derived from histological signatures of biological aging enable tissue-specific aging predictions from blood

Many chronological aging clocks can be found throughout the epigenome: Implications for quantifying biological aging

Underlying features of epigenetic aging clocks in vivo and in vitro

ComputAgeBench: Epigenetic Aging Clocks Benchmark

Cell-type specific epigenetic clocks to quantify biological age at cell-type resolution

Leveraging Single-Cell RNA-Seq to Generate Robust Microglia Aging Clocks

DNAm aging biomarkers are responsive: Insights from 51 longevity interventional studies in humans